The HOPE study and diabetes. Heart Outcomes Prevention Evaluation.
Webster
M W
MW
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D048909:Diabetes Complications; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017257:Ramipril / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D017257:Ramipril